All AbMole products are for research use only, cannot be used for human consumption.
C16-Ceramide is a natural small molecule activating p53 through the direct and selective binding.
C16-Ceramide Preparation, Cell Incubation, and Animal Injection.
C16-ceramide was dissolved in dimethyl sulfoxide (DMSO) and conjugated with 1−2% (w/v) fatty acid-free bovine serum albumin (BSA) by vortexing. Hereafter it is called the C16-ceramide mixture. Primary cortical neurons were washed with serum-free DMEM once, which was followed by treatment with different concentrations or timings of the C16-ceramide mixture. We incubated the cells forming control group with serum-free DMEM containing vehicle solvent plus 1% to 2% fatty acid-free BSA. The vehicle DMSO content was kept to <0.1% (v/v) of the total amount so as not to interfere with effect of reagents.
In order to avoid any possible undesirable effect of DMSO on the mice, C16-ceramide dissolved in mineral oil was delivered into mice via subcutaneous injection 5 days a week for 4 weeks. The dose was adopted 0.18 μg/g body weight on the basis of the plasma concentration reported by Ichi et al. Actually, double-dose 0.36 μg/g body weight was also adopted. The mice were weaned at 3 weeks old and then injected with either C16-ceramide dissolved in mineral oil or mineral oil until they were 7 weeks old.
| Molecular Weight | 537.9 |
| Formula | C34H67NO3 |
| CAS Number | 24696-26-2 |
| Form | Solid |
| Solubility (25°C) | Ethanol 20 mg/mL (warming and heat to 60°C) DMF 20 mg/mL (ultrasonic and warming and heat to 60°C) |
| Storage | 4°C, protect from light |
| Related p53 Products |
|---|
| Pifithrin-α, p-Nitro, Cyclic
Pifithrin-α, p-Nitro, Cyclic (PFN-α) is cell-permeable and active-form p53 inhibitor. Pifithrin-α, p-Nitro, Cyclic behaves as a p53 posttranscriptional activity inhibitor. Pifithrin-α, p-Nitro, Cyclic do not prevent p53 phosphorylation on the S15 residue. |
| PK095
PK095 is a p53 mutant stabilizer. |
| HLI373
HLI373 is an efficacious Hdm2 inhibitor. |
| Cjoc42
Cjoc42 is a compound capable of binding to gankyrin. |
| MDM2-IN-1
MDM2-IN-1 is a synthetic MDM2-p53 interaction (MDM2) inhibitor and contains the trans (D-)configuration. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
